372 related articles for article (PubMed ID: 24403081)
1. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
Gaidhu MP; Fediuc S; Ceddia RB
J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.
Ducommun S; Ford RJ; Bultot L; Deak M; Bertrand L; Kemp BE; Steinberg GR; Sakamoto K
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E688-96. PubMed ID: 24425763
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation.
Jacobs RL; Lingrell S; Dyck JRB; Vance DE
J Biol Chem; 2007 Feb; 282(7):4516-4523. PubMed ID: 17179149
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
6. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
8. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
10. AMPK activation with AICAR provokes an acute fall in plasma [K+].
Zheng D; Perianayagam A; Lee DH; Brannan MD; Yang LE; Tellalian D; Chen P; Lemieux K; Marette A; Youn JH; McDonough AA
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C126-35. PubMed ID: 18003746
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase controls metabolism and heat production during embryonic development in birds.
Walter I; Hegarty B; Seebacher F
J Exp Biol; 2010 Sep; 213(Pt 18):3167-76. PubMed ID: 20802119
[TBL] [Abstract][Full Text] [Related]
12. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways.
Jing M; Cheruvu VK; Ismail-Beigi F
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1071-82. PubMed ID: 18701654
[TBL] [Abstract][Full Text] [Related]
14. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
15. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
16. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
17. Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle.
Glund S; Treebak JT; Long YC; Barres R; Viollet B; Wojtaszewski JF; Zierath JR
Endocrinology; 2009 Feb; 150(2):600-6. PubMed ID: 18818284
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
Bumpus NN; Johnson EF
J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]